Edition:
India

Novozymes A/S (NZYMb.CO)

NZYMb.CO on Copenhagen Stock Exchange

304.60DKK
22 Feb 2019
Change (% chg)

kr.-0.80 (-0.26%)
Prev Close
kr.305.40
Open
kr.305.70
Day's High
kr.306.10
Day's Low
kr.302.20
Volume
343,077
Avg. Vol
506,045
52-wk High
kr.363.10
52-wk Low
kr.260.10

Latest Key Developments (Source: Significant Developments)

Novozymes Q4 EBIT At DKK 1.06 Bln, In Line With Expectations
Thursday, 24 Jan 2019 

Jan 24 (Reuters) - Novozymes A/S ::REG-GROUP FINANCIAL STATEMENT FOR 2018.Q4 SALES DKK 3.71 BILLION (REUTERS POLL DKK 3.79 BILLION).Q4 EBIT DKK 1.06 BILLION (REUTERS POLL DKK 1.06 BILLION).PROPOSED 2018 DIVIDEND OF 5 DKK/SHARE. 11.1% GROWTH IN DIVIDEND. 44.6% PAYOUT RATIO.Q4 NET PROFIT DKK 837 MILLION (REUTERS POLL DKK 823 MILLION).2019 OUTLOOK: ORGANIC SALES GROWTH OF 3-6%, WITH AN ADDITION OF CA. 1 PERCENTAGE POINT FOR GROWTH IN DKK.SEES 2019 SALES GROWTH, ORGANIC 3-6%.FY DIVIDEND DKK 5 PER SHARE (REUTERS POLL DKK 4.77 PER SHARE).SEES 2019 EBIT MARGIN 28-29%.2019 OUTLOOK: EBIT MARGIN AT 28-29% SUPPORTED BY SOLID PRODUCTIVITY GAINS.SEES 2019 NET PROFIT GROWTH 0-5%.2019 OUTLOOK: NET PROFIT GROWTH OF 0-5%..SAYS NEW STOCK BUYBACK PROGRAM IN 2019.TO INITIATE A NEW STOCK BUYBACK PROGRAM FOR 2019 WORTH UP TO DKK 2 BILLION IN TOTAL OR A MAXIMUM OF 20 MILLION SHARES.2019 ROIC EXPECTED AT ABOUT 23% (ABOUT 24% EXCLUDING. IFRS 16 LEASES)..  Full Article

Novozymes CFO says still sees weak Middle East markets in 2019
Thursday, 24 Jan 2019 

Jan 24 (Reuters) - NOVOZYMES A/S CHIEF FINANCIAL OFFICER PRISCA HAVRANEK-KOSICEK SAYS IN TELEPHONE INTERVIEW WITH REUTERS::TREND UNCHANGED IN THE MIDDLE EAST, THE DAMPENING FACTOR FROM THERE CONTINUES IN 2019.UNCERTAINTIES, PARTICULARLY IN THE MIDDLE EAST, ARE THE MAIN REASON FOR A WIDER GUIDANCE RANGE FOR 2019 THAN FOR 2018.THE UNDERLYING GROWTH IN EMERGING MARKETS WITHIN HOUSEHOLD CARE IS VERY, VERY GOOD AND IS EXPECTED TO CONTINUE.REGARDING THE E15 IN THE U.S. WE ARE STILL IN A "WAIT-AND-SEE MODE", WE ARE TAKING A CAUTIOUS APPROACH ON THAT.  Full Article

Attis To Collaborate With Novozymes To Provide Bio-Technology For Ethanol Production
Wednesday, 16 Jan 2019 

Jan 16 (Reuters) - Attis Industries Inc ::ATTIS ANNOUNCES COLLABORATION WITH NOVOZYMES TO PROVIDE BIO-TECHNOLOGY FOR ETHANOL PRODUCTION AT ITS BIOREFINERIES.ATTIS INDUSTRIES - NOVOZYMES HAS COMMITTED TO SUPPLYING ENZYMES REQUIRED BY CO TO CONVERT ITS PULP INTO SUGAR AT ALL OF ITS PLANNED BIOREFINERIES.  Full Article

Novozymes CFO Says Weaker Middle East Growth Is Expected To Continue
Wednesday, 24 Oct 2018 

Oct 24 (Reuters) - NOVOZYMES' CFO PRISCA HAVRANEK-KOSICEK TOLD REUTERS::NOVOZYMES CFO SAYS REASON FOR SALES GROWTH EXPECTED AT LOWER END OF RANGE IS LOWER GROWTH IN THE MIDDLE EAST.NOVOZYMES CFO SAYS LOWER MIDDLE EAST GROWTH IS EXPECTED TO CONTINUE IN THE FOURTH QUARTER.NOVOZYMES CFO SAYS HAD HOPED FOR HIGHER GROWTH IN HOUSEHOLD CARE SO FAR THIS YEAR.NOVOZYMES MAINTAINED ITS ORGANIC SALES GROWTH GUIDANCE OF 4-6 PCT FOR THIS YEAR BUT SAID IT WOULD LIKELY CLOSE THE YEAR TOWARD THE LOWER PART OF THE RANGE nASP0001N0.  Full Article

Novozymes: Q3 net profit at DKK 807 mln
Wednesday, 24 Oct 2018 

Oct 24 (Reuters) - Novozymes A/S ::REG-INTERIM REPORT FOR THE FIRST NINE MONTHS OF 2018.5% ORGANIC SALES GROWTH IN Q3.FULL-YEAR 2018 OUTLOOK: ORGANIC SALES GROWTH OF 4-6% MAINTAINED.Q3 NET PROFIT DKK 807 MILLION (REUTERS POLL DKK 814 MILLION).Q3 EBIT DKK 1.04 BILLION (REUTERS POLL DKK 1.04 BILLION).MAINTAIN ORGANIC REVENUE GROWTH GUIDANCE, WITH THE LIKELIHOOD THAT WILL CLOSE THE YEAR TOWARD THE LOWER PART OF THE RANGE.FULL-YEAR 2018 OUTLOOK: NET PROFIT GROWTH OUTLOOK INCREASED TO 1-3%.Q3 SALES DKK 3.66 BILLION (REUTERS POLL DKK 3.68 BILLION).NET PROFIT GROWTH OUTLOOK INCREASED TO 1-3% ( ABOUT0%)..  Full Article

BioAg Alliance Announces Updated Research And Development Pipeline
Thursday, 4 Jan 2018 

Jan 4 (Reuters) - BioAg Alliance::BIOAG ALLIANCE - ANNOUNCED UPDATED RESEARCH AND DEVELOPMENT PIPELINE.BIOAG ALLIANCE - SEES ACCELERON B-300 SAT TO BE APPLIED TO BETWEEN 8-10 MILLION ACRES IN 2018, WHILE ACCELERON B-360 ST SCHEDULED TO ENTER MARKET IN 2019.BIOAG ALLIANCE - IN 2019-2020, PLAN TO LAUNCH PRODUCTS FOR GROWERS OF CORN, OILSEED RAPE AND WHEAT IN EUROPE.  Full Article

Novozymes Appoints Prisca Havranek-Kosicek New CFO
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - NOVOZYMES ::PRISCA HAVRANEK-KOSICEK NEW CFO.  Full Article

Novozymes CEO Sells 50,000 Of Own Shares
Wednesday, 29 Nov 2017 

Nov 29 (Reuters) - Novozymes ::CEO SELLS 50.000 OF OWN SHARES IN COMPANY FOR A TOTAL VALUE OF DKK 17.2 MILLION.  Full Article

Novozymes completes share buyback program
Friday, 10 Nov 2017 

Nov 10 (Reuters) - NOVOZYMES ::‍NOVOZYMES HAS NOW COMPLETED ANNOUNCED SHARE BUYBACK PROGRAM OF B SHARES WORTH UP TO DKK 2 BILLION IN TOTAL DURING 2017​.  Full Article

Novozymes Q3 EBIT above expectations at DKK 1.06 bln
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - NOVOZYMES ::‍FULL-YEAR OUTLOOK ADJUSTED​.‍NOW EXPECTS ORGANIC REVENUE GROWTH 3-5% (2-5%)​.NOVOZYMES - STILL SOME UNCERTAINTY REGARDING AGRICULTURE-RELATED MARKETS IN Q4‍​.NOW EXPECTS ‍DKK REVENUE GROWTH 2-4% (1-4%)​.NOW EXPECTS ‍EBIT GROWTH 2-4% (1-4%)​.Q3 SALES DKK ‍​3.58 BILLION (REUTERS POLL DKK 3.54 BILLION).Q3 EBIT DKK ‍​1.06 BILLION (REUTERS POLL DKK 1.01 BILLION).Q3 NET PROFIT 819 MILLION (REUTERS POLL DKK 789 MILLION).  Full Article